Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Edwards Lifesciences Corp shares valued at $1,243,065 were sold by Zovighian Bernard J on May 30 ’25. At $77.21 per share, Zovighian Bernard J sold 16,099 shares. The insider’s holdings dropped to 9,564 shares worth approximately $0.73 million following the completion of this transaction.
Also, Zovighian Bernard J sold 967 shares, netting a total of over 74,772 in proceeds. Following the sale of shares at $77.32 each, the insider now holds 8,597 shares.
Before that, Zovighian Bernard J had added 967 shares to its account. In a trade valued at $74,772, the Officer bought Edwards Lifesciences Corp shares for $77.32 each.
As published in a research note from Piper Sandler on April 24, 2025, Edwards Lifesciences Corp [EW] has been rated up from a Neutral to an Overweight and the price target has been revised to $80. Analysts at Stifel upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in late January. As of January 16, 2025, Wolfe Research has decreased its “Peer perform” rating to a “an Underperform” for EW. Earlier on December 16, 2024, BofA Securities upgraded its rating. Their new recommendation was “a Buy” for EW stock which previously was a “a Neutral”.
Analyzing EW Stock Performance
On last trading session,, Edwards Lifesciences Corp [NYSE: EW] rose 0.56% to $75.89. The stock’s lowest price that day was $75.26, but it reached a high of $76.62 in the same session. During the last five days, there has been a drop of approximately -2.42%. Over the course of the year, Edwards Lifesciences Corp shares have jumped approximately 2.51%.
Support And Resistance Levels for Edwards Lifesciences Corp (EW)
RSI (Relative Strength Index) is 48.69 on the 14-day chart, showing neutral technical sentiment.
Is Edwards Lifesciences Corp subject to short interest?
Stocks of Edwards Lifesciences Corp saw a sharp steep in short interest on 2025-05-30 dropping by -2.4 million shares to 5.84 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 8.24 million shares. A decline of -41.09% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.27 of the overall float, the days-to-cover ratio (short ratio) decline to 1.27.
Which companies own the most shares of Edwards Lifesciences Corp (EW)?
In terms of Edwards Lifesciences Corp share price expectations, FactSet research, analysts set an average price target of 75 in the next 12 months, down nearly -0.62% from the previous closing price of $75.47. Analysts anticipate Edwards Lifesciences Corp stock to reach 90 by 2025, with the lowest price target being 74. In spite of this, 17 analysts ranked Edwards Lifesciences Corp stock as Buy at the end of 2025. On October 11, 2024, Morgan Stanley assigned a price target of “an Equal-weight” to the stock and resumed coverage with a $70.
